Sigma-2 Receptors: An Emerging Target for CNS PET Imaging Studies

[1]  D. Mankoff,et al.  Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status , 2019, The Journal of Nuclear Medicine.

[2]  H. Schmidt,et al.  The Molecular Function of σ Receptors: Past, Present, and Future. , 2019, Trends in pharmacological sciences.

[3]  K. Fuxe,et al.  Acute Cocaine Enhances Dopamine D2R Recognition and Signaling and Counteracts D2R Internalization in Sigma1R-D2R Heteroreceptor Complexes , 2019, Molecular Neurobiology.

[4]  Yiyun Huang,et al.  Imaging sigma receptors in the brain: New opportunities for diagnosis of Alzheimer’s disease and therapeutic development , 2019, Neuroscience Letters.

[5]  M. Shin,et al.  Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury. , 2018, ACS chemical neuroscience.

[6]  R. Mach,et al.  Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex , 2018, Scientific Reports.

[7]  B. Blass,et al.  The sigma-2 (σ-2) receptor: a review of recent patent applications: 2013–2018 , 2018, Expert opinion on therapeutic patents.

[8]  Michael D. Wood,et al.  Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors , 2018, Neuropsychopharmacology.

[9]  Yiyun Huang,et al.  18F-Labeled indole-based analogs as highly selective radioligands for imaging sigma-2 receptors in the brain. , 2017, Bioorganic & medicinal chemistry.

[10]  P. Ray,et al.  Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice. , 2017, ACS chemical neuroscience.

[11]  Michael D. Wood,et al.  Identification of the gene that codes for the σ2 receptor , 2017, Proceedings of the National Academy of Sciences.

[12]  A. Crisp,et al.  Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease , 2017, Journal of neurochemistry.

[13]  H. Schmidt,et al.  Structural Perspectives on Sigma-1 Receptor Function. , 2017, Advances in experimental medicine and biology.

[14]  H. Schmidt,et al.  Crystal structure of the human σ1 receptor , 2016, Nature.

[15]  T. Hiranita.  Identification of the Sigma-2 Receptor: Distinct from the Progesterone Receptor Membrane Component 1 (PGRMC1) , 2016, Journal of alcoholism and drug dependence.

[16]  C. McCurdy,et al.  The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes , 2015, EBioMedicine.

[17]  F. Berardi,et al.  Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor. , 2015, European journal of pharmacology.

[18]  Gary Look,et al.  Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity , 2014, PloS one.

[19]  Miles Miller,et al.  Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits , 2014, PloS one.

[20]  R. Mach,et al.  Using SV119‐Gold Nanocage Conjugates to Eradicate Cancer Stem Cells Through a Combination of Photothermal and Chemo Therapies , 2014, Advanced healthcare materials.

[21]  R. Mach,et al.  Quantitative Receptor-Based Imaging of Tumor Proliferation with the Sigma-2 Ligand [18F]ISO-1 , 2013, PloS one.

[22]  R. Mach,et al.  The σ2 receptor: a novel protein for the imaging and treatment of cancer. , 2013, Journal of medicinal chemistry.

[23]  R. Mach,et al.  Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1 , 2013, The Journal of Nuclear Medicine.

[24]  R. Mach,et al.  Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands. , 2012, Surgery.

[25]  R. Hotchkiss,et al.  Characterization and Evaluation of Two Novel Fluorescent Sigma-2 Receptor Ligands as Proliferation Probes , 2011, Molecular imaging.

[26]  R. Hotchkiss,et al.  Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site , 2011, Nature communications.

[27]  R. Mach,et al.  Radiosynthesis and biological evaluation of a promising sigma(2)-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET/SPECT probe for imaging breast cancer. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[28]  K. Fuxe,et al.  Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine , 2010, Proceedings of the National Academy of Sciences.

[29]  R. Craven,et al.  Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity* , 2010, The Journal of Biological Chemistry.

[30]  R. Craven,et al.  Progesterone Receptor Membrane Component 1 (Pgrmc1): A Heme-1 Domain Protein That Promotes Tumorigenesis and Is Inhibited by a Small Molecule , 2010, Journal of Pharmacology and Experimental Therapeutics.

[31]  T. Fehm,et al.  Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1 , 2009, Breast Cancer Research.

[32]  K. Leenders,et al.  Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors—The cases of ketamine and haloperidol , 2008, Neurochemistry International.

[33]  T. Fehm,et al.  Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1 , 2008, Breast Cancer Research.

[34]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.

[35]  R. Hotchkiss,et al.  Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. , 2007, Cancer research.

[36]  M. Cahill.  Progesterone receptor membrane component 1: An integrative review , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  R. Mach,et al.  Carbon-11 labeled σ2 receptor ligands for imaging breast cancer , 2005 .

[38]  R. Mach,et al.  [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe. , 2005, European journal of pharmacology.

[39]  W. Bowen,et al.  Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. , 2004, European journal of pharmacology.

[40]  R. Mach,et al.  Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands , 2004 .

[41]  R. Mach,et al.  Sigma-2 receptors as a biomarker of proliferation in solid tumours , 2000, British Journal of Cancer.

[42]  R. Mach,et al.  Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells , 1999, British Journal of Cancer.

[43]  R. Mach,et al.  Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. , 1997, Cancer research.

[44]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Bowen,et al.  Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. , 1995, Cancer research.

[46]  W. Bowen,et al.  Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling , 1994 .

[47]  W. Bowen,et al.  A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain , 1990, Brain Research.

[48]  W. Bowen,et al.  Evidence for a multi-site model of the rat brain σ receptor , 1989 .

[49]  T. Su.  Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1982, The Journal of pharmacology and experimental therapeutics.

[50]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.